INTRODUCTION
In retinal dystrophies and age-related macular degeneration (AMD), visual loss occurs as a consequence of photoreceptor degeneration. As a result, a secondary process of partial trans-synaptic degeneration occurs affecting neurons distal to the degenerating photoreceptors. There is histological evidence of some degree of ganglion cell sparing. [1] [2] [3] [4] [5] Humayun and co-workers have reported that in vivo electrical stimulation of surviving retinal ganglion cells was able to generate phosphenes correlated spatially and temporally with the stimuli, demonstrating that these neurons were still able to convey visual information to the brain. [6] [7] These findings support the assumption that electrical stimulation of surviving retinal cells by a retinal prosthesis might restore useful vision in ARMD or retinal dystrophy.
Strategies which have been proposed in order to trigger coordinated ganglion cell activity include subretinal stimulation, [8] [9] [10] epiretinal stimulation on the retinal inner limiting membrane [11] [12] [13] [14] [15] [16] or perineural stimulation around the optic nerve. [17] [18] The efficacy and safety of retinal implants have been investigated in different animal species in vivo. A number of critical issues remain outstanding, such as surgical techniques, stimulation protocols, implant tolerance and biocompatibility.
Subretinal prostheses have been implanted in living wild type pigs and cats where photoreceptors facing the implants eventually underwent degeneration associated with glial tissue formation. [19] The retinal response to light was not however significantly altered by the presence of the implant as indicated by ERG an animal model of retinitis pigmentosa, in order to demonstrate that the subretinal implant could slow the congenital retinal degeneration. [23] This photoreceptor rescue was ascribed to a trophic effect of the implant on the retina. A similar effect was seen in human experiments where visual performance improved at sites distant from the implant itself. [24] The aim of this study was to design a surgical approach in vivo in the rat eye using a subretinal implant activated by an external connector in order to evaluate the efficacy and safety of the stimuli on the retina. The dystrophic P23H rat was selected for these experiments because this animal model of retinitis pigmentosa may provide a similar biological environment to patients with inherited photoreceptor degeneration. The study shows that subretinal implants can be inserted for long termstudies.
MATERIALS AND METHODS

Implants
Initial experiments were conducted with inert polyimide (type PI2611) prototypes in order to test the technique and feasibility of the procedure. In later experiments, we implanted devices with one or several platinum electrodes with a 25µm radius. These were produced at the Laboratory of Microsystems, EPFL, using a standard procedure. [25] In brief, a layer of 11 µm polyimide (PI12611, HD Microsystems) was applied by spin-coating, and subsequently cured. A 200 nm-thick layer of platinum was deposited on the polyimide, using titanium as the adhesion layer. The electrodes were shaped using dry etching. A second layer of polyimide was then deposited, and the implant shape and electrode openings were engineered by dry etching. The final total implant thickness was 22 µm. The electrodes were then 5 soaked in 10% HCl and calibrated using Cole-Palmer® traceable test solutions. To allow diffusion of nutrients and waste products, some implants were also supplied with through-holes with a diameter of 25 µm (Fig 1, 2a) . 
Animals
Histology
At 9 weeks animals were anesthetized as described above to allow an intracardiac perfusion of 4% paraformaldehyde in phosphate buffer 0.1M (pH= 7.4) at a 10ml/min rate after clamping blood vessels irrigating the inferior part of the body.
Once the eye was enucleated, the cornea and lens were removed by circumferential incision anterior to the ora serrata. The implant tail was sectioned in order to maintain the implant head in the subretinal space. Eye cups were incubated overnight at 4°C in phosphate buffer (0,1M ; pH=7,4) containing 4% paraformaldehyde and 2.5% glutaraldehyde. After several washes in phosphate buffer, the tissue was postfixed in osmium tetroxide 1% for 30 min at room temperature and rapidly rinsed in water.
Finally, the tissue was dehydrated in alcohol and embedded in epoxy resin. Semithin sections were obtained by ultramicrotome sectioning (Ultracut®, Leica) with a histodiamond (45°, 8 mm diatome), and stained with toluidine blue. Figure 2 shows two different subretinal implants observed in vivo in the fundus. The first implant prototypes were polyimide (type PI2611) bases only to assess the feasibility of the surgical procedure using various head shapes. Implant head diameters > 1mm required large circumferential sclerotomies. Larger prototypes were difficult to adapt to the tight curvature of the eye. Prototypes with a smaller head diameter were also used but were abandoned as they did not provide sufficient space for multiple channel electrodes. Symmetrical head designs were easier to insert under the retina and did not undergo lateral slippage during insertion as was the case for asymmetrical designs. The most suitable prototype had a symmetrical head design with a 1000 µm diameter size and a connecting tail 250 µm large and 4 cm long ( fig   2b) . These prototypes were 22µm thick.
RESULTS
Implantation and imaging
During this process, 26 rats underwent subretinal implantation in 5 operating sessions. Postoperative examinations confirmed that the implants were in the subretinal space when retinal vessels were seen passing over the device. Fourteen of 26 implants were satisfactorily positioned in the subretinal space (54%); the success rate in the last 10 operated animals was 70%. A number of post-implantation extrusions reduced the very high initial success rate for subretinal space positioning.
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After up to 1.5 months, SLO imaging of the retinae showed no fibrous reaction in the vicinity of the implant and macroscopically normal tissue (Fig 2) . In one case, however, a hemorrhagic retinal detachment was observed at the level of the implant head.
After establishing the most appropriate shape for the implant we then investigated how an external connector at the distal end of the implant could be made reliably accessible for repeated stimulations and recordings on the living animal. This external connector (6 male pins) connected to the implant tail was glued onto a plexiglass plate with araldite. Implantation was performed under general anesthesia.
A cutaneous incision on the cranial apex was performed and 2 small bore-screws inserted into the cranial apex as previously described for the stabilisation of intracerebral injection cannulae. [26] A subcutaneous track was made between the lateral superior fornix of the implanted eye and the skin incision with a 16 G cannula.
The implant head was 'fed' through this track distal to proximal before being inserted under the retina. Once the intraocular procedure was completed, the proximal electrical connector plate was fixed with dental cement to the bore-screws in the skull The rapid curing of the paste provided a stable resting platform for the connector. In order to safeguard it from post-surgical damage, the connector was protected in a casing made out of the proximal end of a screw-top Eppendorf tube. To assess whether stimulations can be applied on non-anesthetized rats, sequential impedance measurements were achieved one week after implantation by applying a 50 mV sine wave at different frequencies. In figure 3A , wires are seen leaving the implant connector on the non-anesthetized rat head and linking up with an LCR meter (seen in the background) via four BNC cables. Figure 3B illustrates the stability of the impedance measurements at 0, 15 and 60 minutes.
Retinal semi-thin sections confirmed that the retinal tissue was not greatly altered in the vicinity of the implant (Fig 4) . In average, ganglion cells were observed at a distance of 149.9 µm (± 25.7 µm s.e.m., n=5) from the implant below the retina.
CONCLUSION
This study demonstrated that it was possible to implant platinum electrodes into the subretinal space of the P23H rat and to maintain a stable electrical connection between the electrodes and the extraocular connector, notwithstanding mechanical stress on the connector cable. The implants remained in the subretinal space for up to 1.5 months without histological evidence of glial scarring. The few cases of proliferative vitreoretinopathy were attributed to the surgeon's learning curve.
Subretinal implantation of various implant designs in mammals such as the cat, the rabbit , the non-dystrophic laboratory swine and the RCS rat have previously been reported [24] [27] . In the latter, the subretinal implant was selfpowered and no external cabling was required [24] . Implantation in the rat, pig and cat has been obtained by elevating the retina with a subretinal fluid injection through a sclerotomy to create an iatrogenic retinal detachment [21] [22] [24] [27] [28] . The implantation method is simple and reproducible. Subretinal access is achieved by sclerotomy or sclerectomy without entering the vitreous cavity (ab externo) or by retinotomy or limbal sclerotomy using a vitrectomy approach (ab interno). The latter techniques have been used in rabbits [9] , minipigs [29] and cats [30] . Given the size of the rat globe and lens, this approach is not possible with current instrumentation.
Zrenner and co-workers developed a custom-made implantation tool for multiphotodiode array (MPDA) implantation in the rat subretinal space [31] .
However, these MPDAs were stand-alone devices without the extraocular wire connexion used in our experiments. Subretinal implants have also been introduced in dystrophic RCS rats in order to demonstrate the neuroprotective effects of implantation, which were noted with both active and inactive implants [24] . These trophic effects, akin to those reported after phosphate buffer injection into the subretinal space [32] were ascribed to the effect of the surgery itself on the retina.
RCS rats have defective phagocytosis of photoreceptor outer segments by the RPE. This results from a recessively transmitted Mertk mutation which is solely expressed in the RPE. [33] In this study we used P23H transgenic rats with the opsin mutation responsible for the most common form of autosomal dominant retinitis pigmentosa (adRP). Line 1 rats, which were used in these experiments, have the highest level of transgene expression and the fastest rate of photoreceptor degeneration. Histopathological and electrophysiological studies have shown broad similarities between human adRP P23H mutation and P23H rat retinal degeneration.
[34]
The difference in activation threshold between normal and dystrophic human retina that was reported with epiretinal implants further supports the use of a dystrophic mammal model to evaluate stimulating electrodes and protocols. Although surgery in the rat is difficult given the small globe and large lens [35] , dystrophic rats, with a life-span of up to 2 yrs, provide a unique model in which long term stimulation of the retina can be performed. Electrophysiological measurements were recently achieved in vivo on rats just after implantation but were not performed following chronic stimulations. [36] In further studies on P23H rats, which are readily available at a low cost relative to cats or pigs, we plan to investigate the safety and efficacy of long term retinal stimulation using the electrical connector attached to the animal's head as shown in fig 2 as well as changes in electrical impedance over time using electrical impedance spectroscopy, a technique with which it is possible to simultaneously characterize the conductivity of a tissue sample and the surface properties of the electrodes. [37] The distance between implant and the retinal tissue as observed on histological sections already suggest that appropriate electrical stimulations of retinal cells should produce activation of visual centers.
Various electrode sizes have been implanted into the subretinal space: 8 platinum electrodes of 100 µm x 100µm for direct electrical stimulation of the retina in the pig and rabbit [27] , an array of up to 5000 photodiodes with 20µm x 20 µm electrodes powered by incident light in the cat [28] , a 2 mm diameter, 25µ thick chip with approximately 5000 independent microphotodiodes in human volunteers [23] Our prototype has similar sized electrodes (25µm x25 µm), as we aim to produce a retinal implant with 100µm square pixel size stimuli. Our group recently reported that a 3.5°x10° 'window' containing 286 pixels with a 100 µm square size was sufficient to allow reading of 4 letter words at 15° of eccentricity and that a window enlarged to 7°x10° (572 pixels) allowed fluent text reading [38] [39] . Based on these results, we designed stimulating test heads with 4 circular 25 µm radius electrodes and a center-to-center spacing of 150 µm to allow for the generation of pixels >100 µm. The 1000 µm diameter supporting base of our implant head could allow larger electrodes to be fitted if the current small-sized electrodes were unable to provide long term stimulations below the retinal safety threshold. 
